Citation | Xue, CB; Feng, H; Cao, G; Huang, T; Glenn, J; Anand, R; Meloni, D; Zhang, K; Kong, L; Wang, A; Zhang, Y; Zheng, C; Xia, M; Chen, L; Tanaka, H; Han, Q; Robinson, DJ; Modi, D; Storace, L; Shao, L; Sharief, V; Li, M; Galya, LG; Covington, M; Scherle, P; Diamond, S; Emm, T; Yeleswaram, S; Contel, N; Vaddi, K; Newton, R; Hollis, G; Friedman, S; Metcalf, B Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist. ACS Med Chem Lett2:450-454 (2011) [PubMed] Article |
---|
SMILES | O[C@]1(CC[C@@H](CC1)N1CC[C@H](C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccncn1 |r,wU:4.7,wD:10.13,1.0,(-5.51,-34.96,;-4.74,-36.3,;-3.93,-37.62,;-2.4,-37.59,;-1.65,-36.24,;-2.45,-34.92,;-3.99,-34.95,;-.11,-36.21,;.81,-37.43,;2.27,-36.93,;2.24,-35.39,;.76,-34.94,;3.56,-34.6,;4.9,-35.36,;4.92,-36.9,;6.23,-34.57,;7.57,-35.32,;8.9,-34.54,;8.88,-33,;10.24,-35.29,;10.25,-36.83,;11.59,-37.58,;12.92,-36.8,;12.89,-35.25,;11.55,-34.5,;14.21,-34.46,;15.56,-35.21,;14.19,-32.92,;15.54,-33.68,;-6.28,-36.34,;-7.08,-35.03,;-8.61,-35.06,;-9.36,-36.41,;-8.56,-37.73,;-7.02,-37.7,)| |